Best Growth Stocks To Watch Now – June 17th

Circle Internet Group, Digital Turbine, Novo Nordisk A/S, Blueprint Medicines, BlackRock, SpringWorks Therapeutics, and Blackstone are the seven Growth stocks to watch today, according to MarketBeat’s stock screener tool. Growth stocks are shares of companies expected to grow their revenues and earnings at a faster pace than the overall market. These firms typically reinvest most of their profits back into research, development, and expansion rather than paying out dividends. Because investors anticipate strong future performance, growth stocks often trade at higher price-to-earnings multiples and carry greater volatility. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Circle Internet Group (CRCL)

Founded in 2013, Circle’s mission is to raise global economic prosperity through the frictionless exchange of value. We intend to connect the world more deeply by building a new global economic system on the foundation of the internet, and to facilitate the creation of a world where everyone, everywhere can share value as easily as we can today share information, content, and communications.

Shares of CRCL stock traded down $2.86 on Tuesday, hitting $148.20. 21,454,910 shares of the stock traded hands, compared to its average volume of 33,805,520. Circle Internet Group has a 52 week low of $64.00 and a 52 week high of $165.60.

Digital Turbine (APPS)

Digital Turbine, Inc., through its subsidiaries, operates a mobile growth platform for advertisers, publishers, carriers, and device original equipment manufacturers (OEMs). The company operates through two segments, On Device Solutions and App Growth Platform. Its application media platform delivers mobile applications to various publishers, carriers, OEMs, and devices; and content media platform offers news, weather, sports, and other content, as well as programmatic advertising and media content delivery services, and sponsored and editorial content media.

APPS stock traded up $2.45 during trading on Tuesday, reaching $7.26. The company’s stock had a trading volume of 58,209,253 shares, compared to its average volume of 4,684,759. Digital Turbine has a 1 year low of $1.18 and a 1 year high of $7.61. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 2.50. The company has a market capitalization of $762.25 million, a P/E ratio of -2.42 and a beta of 2.58. The company’s fifty day moving average is $3.94 and its 200-day moving average is $3.19.

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

NVO traded down $2.52 on Tuesday, hitting $74.50. 4,421,715 shares of the company’s stock traded hands, compared to its average volume of 9,433,907. The company’s 50 day simple moving average is $67.61 and its 200-day simple moving average is $79.24. The company has a current ratio of 0.74, a quick ratio of 0.55 and a debt-to-equity ratio of 0.62. Novo Nordisk A/S has a one year low of $57.00 and a one year high of $148.15. The firm has a market cap of $334.32 billion, a price-to-earnings ratio of 22.64, a P/E/G ratio of 0.90 and a beta of 0.66.

Blueprint Medicines (BPMC)

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of indolent SM, and other mast cell disorders.

Shares of NASDAQ:BPMC traded down $0.06 during midday trading on Tuesday, reaching $128.19. 2,179,121 shares of the company were exchanged, compared to its average volume of 1,222,584. The stock has a market cap of $8.28 billion, a PE ratio of -118.70 and a beta of 0.84. The business’s fifty day moving average is $101.00 and its two-hundred day moving average is $97.27. Blueprint Medicines has a one year low of $73.04 and a one year high of $128.59. The company has a current ratio of 2.85, a quick ratio of 2.80 and a debt-to-equity ratio of 1.15.

BlackRock (BLK)

BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.

Shares of BLK stock traded down $10.27 during trading hours on Tuesday, hitting $971.83. The stock had a trading volume of 187,437 shares, compared to its average volume of 814,995. The company has a debt-to-equity ratio of 0.45, a current ratio of 5.23 and a quick ratio of 5.23. The stock has a market capitalization of $150.56 billion, a price-to-earnings ratio of 23.14, a PEG ratio of 1.90 and a beta of 1.41. BlackRock has a one year low of $773.74 and a one year high of $1,084.22. The stock’s 50-day moving average price is $941.17 and its two-hundred day moving average price is $971.08.

SpringWorks Therapeutics (SWTX)

SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is OGSIVEO (nirogacestat), an oral small molecule gamma secretase inhibitor that is in Phase III DeFi trial for the treatment of desmoid tumors; and Nirogacestat, is also in Phase 2 clinical development as a monotherapy for the treatment of ovarian granulosa cell tumors (GCT), a subtype of ovarian cancer.

NASDAQ:SWTX traded down $0.01 during trading hours on Tuesday, reaching $46.87. The stock had a trading volume of 3,719,880 shares, compared to its average volume of 2,398,932. The stock has a market capitalization of $3.53 billion, a PE ratio of -13.47 and a beta of 0.70. SpringWorks Therapeutics has a 52 week low of $28.21 and a 52 week high of $62.00. The company has a 50 day moving average price of $44.28 and a two-hundred day moving average price of $43.87.

Blackstone (BX)

Blackstone Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage companies. It also provide capital markets services.

BX traded down $2.46 during trading hours on Tuesday, hitting $135.80. The company’s stock had a trading volume of 1,021,914 shares, compared to its average volume of 4,361,031. Blackstone has a 12 month low of $115.66 and a 12 month high of $200.96. The company has a current ratio of 0.67, a quick ratio of 0.71 and a debt-to-equity ratio of 0.61. The business’s 50-day moving average price is $136.88 and its 200-day moving average price is $155.02. The stock has a market cap of $99.09 billion, a price-to-earnings ratio of 37.41, a P/E/G ratio of 1.07 and a beta of 1.65.